Regulatory Expertise That Moves Programs Forward

Proactive Regulatory Support Across the Product Lifecycle

Navigating regulatory pathways requires more than compliance. It requires foresight, structure, and the ability to align development and manufacturing with evolving global expectations.

At OneSource, regulatory expertise is embedded across the product lifecycle. From early product development through clinical and commercial manufacturing, teams work in close coordination to ensure that data, processes, and documentation are aligned per regulatory standards for successful submission and approval.

This integrated approach enables clients to move forward with confidence, supported by regulatory strategies that are both proactive and execution-focused.

5

state-of-the-art facilities with approvals from major global regulatory agencies

20+

years of regulatory compliance experience

Global Presence Icon

Strong track record of successful audits and inspections

End-to-end regulatory support

OneSource supports clients across the full spectrum of regulatory activities, from development through commercial supply.

Our teams contribute to the preparation of comprehensive data packages, supported by detailed analytical characterization and manufacturing documentation. This ensures that submissions are built on a strong and consistent foundation. Our commitment is to provide to right-first-time submissions and follow a quality-centric approach.

  • Preparation of pre-submission meeting packages to facilitate interaction with regulators for complex products and 505(b)(2) filings
  • Develop tailored regulatory strategies that align with business objectives
  • Provide post-approval filing strategies to support the full product life cycle
  • Authoring technical documents & compilation of dossiers to support global submissions in CTD & eCTD formats
  • Alignment of CMC (Chemistry, Manufacturing, and Controls) data meeting regulatory expectations reducing the risk of delays in obtaining product approval
  • Support for clinical and commercial manufacturing campaigns tied to approval milestones.
  • Coordination across development, quality, and manufacturing teams.

This integrated model helps reduce delays, streamline communication, and support more efficient progression through regulatory pathways.

Experience across global regulatory pathways

OneSource brings experience supporting a range of regulatory pathways across major markets, including:

  • New Chemical Entities (NCE-1)
  • Abbreviated New Drug Applications (ANDA)
  • Paragraph IV (Para IV) filings
  • 505(b)(2) pathways
  • Centralized Procedure (CP)
  • De-centralized Procedure (DCP)
  • Mutual Recognition Procedure (MRP)
  • National Procedure (NP)
  • Abbreviated New Drug Submission (ANDS)

Each pathway presents unique requirements, from data expectations to submission strategy. By aligning development and manufacturing activities with these requirements early, OneSource helps clients avoid rework and accelerate timelines.

Aligning development and manufacturing with regulatory expectations

A key differentiator in regulatory success is the alignment between development data and manufacturing execution.

At OneSource, regulatory considerations are integrated into:

  • Product development and characterization
  • Process development and scale-up
  • Manufacturing and validation activities

This ensures that data generated across the lifecycle is consistent, traceable, and suitable for regulatory review. By embedding regulatory thinking into operational workflows, OneSource helps reduce risk and improve the quality of submissions.

Global regulatory standards across our facilities

OneSource’s facilities operate in alignment with global regulatory expectations and are regularly inspected by leading health authorities.

Approvals across the network include agencies such as:

  • US FDA
  • EMA
  • MHRA
  • ANVISA
  • TGA
  • WHO
  • Health Canada

These approvals reflect a consistent commitment to compliance and support the ability to supply products into highly regulated markets.

Start your therapeutic development program

Reach out to us